Shirakura, T., Nomura, J., Matsui, C., Kobayashi, T., Tamura, M., & Masuzaki, H. (2016). Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol.
Chicago Style aipamenaShirakura, Takashi, Johji Nomura, Chieko Matsui, Tsunefumi Kobayashi, Mizuho Tamura, and Hiroaki Masuzaki. "Febuxostat, a Novel Xanthine Oxidoreductase Inhibitor, Improves Hypertension and Endothelial Dysfunction in Spontaneously Hypertensive Rats." Naunyn Schmiedebergs Arch Pharmacol 2016.
MLA aipamenaShirakura, Takashi, et al. "Febuxostat, a Novel Xanthine Oxidoreductase Inhibitor, Improves Hypertension and Endothelial Dysfunction in Spontaneously Hypertensive Rats." Naunyn Schmiedebergs Arch Pharmacol 2016.